ASX - By Stock
|
PAR |
Re:
General OA media and info
|
|
JamesTas
|
670 |
247K |
7 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
670
|
247K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Type D Response Submitted and Received by the US FDA
|
|
JamesTas
|
46 |
14K |
1 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
46
|
14K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Type D Response Submitted and Received by the US FDA
|
|
JamesTas
|
46 |
14K |
8 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
46
|
14K
|
8
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
JamesTas
|
427 |
119K |
1 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
427
|
119K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
JamesTas
|
427 |
119K |
4 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
427
|
119K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
JamesTas
|
427 |
119K |
20 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
427
|
119K
|
20
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
JamesTas
|
427 |
119K |
23 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
427
|
119K
|
23
|
|
ASX - By Stock
|
PAR |
Re:
Resolution of lumbar bone marrow oedema
|
|
JamesTas
|
76 |
35K |
16 |
01/04/24 |
01/04/24 |
ASX - By Stock
|
76
|
35K
|
16
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
JamesTas
|
4.2K |
3.7M |
11 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
4.2K
|
3.7M
|
11
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
JamesTas
|
4.2K |
3.7M |
3 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
4.2K
|
3.7M
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Final Director's Interest Notice
|
|
JamesTas
|
19 |
5.5K |
5 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
19
|
5.5K
|
5
|
|
ASX - By Stock
|
FRX |
Re:
Ann: Half Yearly Report and Accounts
|
|
JamesTas
|
24 |
5.5K |
2 |
05/03/24 |
05/03/24 |
ASX - By Stock
|
24
|
5.5K
|
2
|
|
ASX - By Stock
|
FRX |
Re:
Ann: Half Yearly Report and Accounts
|
|
JamesTas
|
24 |
5.5K |
10 |
05/03/24 |
05/03/24 |
ASX - By Stock
|
24
|
5.5K
|
10
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Half Yearly Report and Accounts
|
|
JamesTas
|
37 |
12K |
0 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
37
|
12K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
JamesTas
|
236 |
77K |
4 |
02/02/24 |
02/02/24 |
ASX - By Stock
|
236
|
77K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
JamesTas
|
236 |
77K |
1 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
236
|
77K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
JamesTas
|
236 |
77K |
13 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
236
|
77K
|
13
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
JamesTas
|
974 |
315K |
12 |
17/01/24 |
17/01/24 |
ASX - By Stock
|
974
|
315K
|
12
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Successful completion of Retail Entitlement Offer
|
|
JamesTas
|
95 |
28K |
5 |
01/01/24 |
01/01/24 |
ASX - By Stock
|
95
|
28K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
AGM Meeting
|
|
JamesTas
|
92 |
32K |
27 |
02/12/23 |
02/12/23 |
ASX - By Stock
|
92
|
32K
|
27
|
|
ASX - By Stock
|
PAR |
Re:
If the claim is....then why ?
|
|
JamesTas
|
26 |
6.0K |
6 |
30/11/23 |
30/11/23 |
ASX - By Stock
|
26
|
6.0K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Ann: 2023 AGM Chairman Address
|
|
JamesTas
|
18 |
5.7K |
2 |
29/11/23 |
29/11/23 |
ASX - By Stock
|
18
|
5.7K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Ann: 2023 AGM Chairman Address
|
|
JamesTas
|
18 |
5.7K |
2 |
29/11/23 |
29/11/23 |
ASX - By Stock
|
18
|
5.7K
|
2
|
|
ASX - By Stock
|
FRX |
FRX Shop front
|
|
JamesTas
|
1 |
564 |
2 |
29/11/23 |
29/11/23 |
ASX - By Stock
|
1
|
564
|
2
|
|
ASX - By Stock
|
PAR |
Re:
AGM 2024 - QUESTIONS
|
|
JamesTas
|
151 |
45K |
1 |
29/11/23 |
29/11/23 |
ASX - By Stock
|
151
|
45K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
JamesTas
|
40 |
12K |
0 |
28/11/23 |
28/11/23 |
ASX - By Stock
|
40
|
12K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Updated Strategy and Investor Presentation
|
|
JamesTas
|
508 |
120K |
1 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
508
|
120K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
A 101 on PAR options...
|
|
JamesTas
|
44 |
13K |
2 |
04/11/23 |
04/11/23 |
ASX - By Stock
|
44
|
13K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Trading Halt
|
|
JamesTas
|
62 |
21K |
2 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
62
|
21K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm to Recommence Trading
|
|
JamesTas
|
10 |
4.0K |
6 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
10
|
4.0K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Trading Halt
|
|
JamesTas
|
108 |
28K |
4 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
108
|
28K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Trading Halt
|
|
JamesTas
|
108 |
28K |
8 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
108
|
28K
|
8
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Trading Halt
|
|
JamesTas
|
108 |
28K |
16 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
108
|
28K
|
16
|
|
ASX - By Stock
|
PAR |
Re:
Fin Rev- Paradigm looking to raise funds
|
|
JamesTas
|
101 |
29K |
1 |
29/10/23 |
29/10/23 |
ASX - By Stock
|
101
|
29K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Fin Rev- Paradigm looking to raise funds
|
|
JamesTas
|
101 |
29K |
6 |
29/10/23 |
29/10/23 |
ASX - By Stock
|
101
|
29K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Ann: iPPS Increases Cartilage Thickness in Phase 2 Trial
|
|
JamesTas
|
218 |
73K |
17 |
18/10/23 |
18/10/23 |
ASX - By Stock
|
218
|
73K
|
17
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene Shows Broad Anti-Cancer Activity in Cancer Cells
|
|
JamesTas
|
218 |
71K |
6 |
21/09/23 |
21/09/23 |
ASX - By Stock
|
218
|
71K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
JamesTas
|
4.2K |
3.7M |
16 |
15/09/23 |
15/09/23 |
ASX - By Stock
|
4.2K
|
3.7M
|
16
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm Accepted for Presentations at Major Conferences
|
|
JamesTas
|
24 |
8.6K |
29 |
01/09/23 |
01/09/23 |
ASX - By Stock
|
24
|
8.6K
|
29
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Annual Financial Results and Operational Update
|
|
JamesTas
|
60 |
24K |
8 |
31/08/23 |
31/08/23 |
ASX - By Stock
|
60
|
24K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Annual Financial Results and Operational Update
|
|
JamesTas
|
60 |
24K |
14 |
31/08/23 |
31/08/23 |
ASX - By Stock
|
60
|
24K
|
14
|
|
ASX - By Stock
|
ABB |
Re:
Ann: ABB FY23 Annual Results Announcement
|
|
JamesTas
|
25 |
14K |
0 |
25/08/23 |
25/08/23 |
ASX - By Stock
|
25
|
14K
|
0
|
|
ASX - By Stock
|
ABB |
Re:
Ann: ABB FY23 Annual Results Announcement
|
|
JamesTas
|
25 |
14K |
2 |
25/08/23 |
25/08/23 |
ASX - By Stock
|
25
|
14K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
dangerous territory
|
|
JamesTas
|
6 |
4.0K |
5 |
25/08/23 |
25/08/23 |
ASX - By Stock
|
6
|
4.0K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
JamesTas
|
974 |
315K |
0 |
24/08/23 |
24/08/23 |
ASX - By Stock
|
974
|
315K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
JamesTas
|
974 |
315K |
1 |
24/08/23 |
24/08/23 |
ASX - By Stock
|
974
|
315K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
JamesTas
|
4.2K |
3.7M |
6 |
22/08/23 |
22/08/23 |
ASX - By Stock
|
4.2K
|
3.7M
|
6
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Strategic Update August 2023
|
|
JamesTas
|
592 |
183K |
1 |
18/08/23 |
18/08/23 |
ASX - By Stock
|
592
|
183K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Strategic Update August 2023
|
|
JamesTas
|
592 |
183K |
40 |
17/08/23 |
17/08/23 |
ASX - By Stock
|
592
|
183K
|
40
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
JamesTas
|
72 |
26K |
2 |
07/08/23 |
07/08/23 |
ASX - By Stock
|
72
|
26K
|
2
|
|